Abiranamo 250mg (Generic Zytiga) Melbourne — Abiraterone Acetate for Prostate Cancer | Victoria, Australia 2026
Product Details
Abiranamo 250mg contains Abiraterone Acetate 250mg, an androgen biosynthesis inhibitor used in combination with corticosteroids for the treatment of specific types of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC), as prescribed by an oncology specialist.
At Unnati Pharmax, we export high-quality generic Abiraterone tablets manufactured in WHO-GMP-certified Indian facilities to customers in Melbourne, Victoria, Australia, and other international destinations, subject to local import regulations.
Product Specifications
| Brand Name | Abiranamo 250mg |
| Generic Name | Abiraterone Acetate |
| Strength | 250 mg |
| Dosage Form | Tablets |
| Therapeutic Category | Oncology |
| Indications | Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Castration-Sensitive Prostate Cancer (mCSPC), as prescribed |
| Drug Class | Androgen Biosynthesis Inhibitor (CYP17 Inhibitor) |
| Route of Administration | Oral |
| Storage | Store below 25°C in a cool, dry place away from moisture and sunlight |
| Prescription Required | Yes |
| Manufacturer | Indian WHO-GMP Certified Manufacturer |
| Export Availability | Melbourne, Victoria, Australia & International Markets |
Key Features
- Contains Abiraterone Acetate 250mg
- Generic alternative to Zytiga®
- Used for the treatment of eligible patients with advanced prostate cancer under specialist supervision
- Oral tablet formulation
- Manufactured in WHO-GMP-certified facilities
- Quality-tested with export-grade packaging
- Competitive pricing for international markets
- Available for pharmacies, hospitals, wholesalers, and licensed importers
- Secure worldwide shipping from India
- Export documentation and parcel tracking available
Industry Update
Abiraterone acetate remains a key hormonal therapy for the treatment of advanced prostate cancer and is widely incorporated into international oncology guidelines for appropriate patients with mCRPC and mCSPC. Ongoing clinical research continues to evaluate optimal sequencing and combination strategies with androgen receptor inhibitors, chemotherapy, and targeted therapies to improve long-term outcomes. The increasing availability of high-quality generic abiraterone has expanded access to treatment globally while helping reduce healthcare costs. Treatment should always be initiated and monitored by an oncology specialist according to current clinical guidelines.
Melbourne's Peter MacCallum Cancer Centre — Australia's only dedicated cancer hospital and one of the world's top ten — alongside the Royal Melbourne Hospital, Alfred Hospital, and Monash Health manage prostate cancer for Victoria's 6.7 million population. Melbourne's diverse Greek, Italian, Chinese, Indian, and Vietnamese communities create distinct prostate cancer demographic patterns. Australia has one of the world's highest prostate cancer incidence rates from widespread PSA screening. Abiranamo 250mg provides Melbourne's advanced prostate cancer patients with life-extending Abiraterone at dramatically reduced cost versus Victorian pharmacy brand pricing.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com
FAQ 1: How does Peter MacCallum Cancer Centre's world-leading prostate cancer programme shape Abiranamo use for Melbourne patients?
Peter MacCallum Cancer Centre — universally called "Peter Mac" by Melburnians — moved in 2016 to a landmark $1 billion building in Melbourne's biomedical precinct adjacent to the Royal Melbourne Hospital and University of Melbourne, creating Australia's most integrated cancer research and treatment campus. Peter Mac's prostate cancer programme — led by internationally recognised clinicians including radiation oncology, medical oncology, and urology specialists — manages prostate cancer across the full spectrum from localised to metastatic castration-resistant disease. Abiranamo 250mg in Peter Mac's mCRPC and mCSPC protocols: Peter Mac follows the most current ESMO and Cancer Council Australia guidelines — initiating Abiranamo 250mg + Prednisone simultaneously with ADT for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) based on the LATITUDE and STAMPEDE evidence; continuing Abiranamo for mCRPC patients who have progressed on ADT alone; and incorporating the newer fine-particle formulation (Yonsa) discussion for patients who find the 4-tablet fasting protocol challenging. PBS coverage for Abiranamo in Victoria: Abiraterone Acetate is PBS-listed for mHSPC (with enzalutamide as alternative) and mCRPC with prior docetaxel for Medicare-eligible Australians; Peter Mac's pharmacy dispenses PBS-subsidised Abiraterone for eligible patients at PBS co-payment. Abiranamo 250mg from Unnati Pharmax serves Melbourne patients ineligible for PBS (significant international prostate cancer patients attending Peter Mac for advanced treatment), those in PBS authority processing gaps, and cost-optimising patients with high Medicare Lifetime Safety Net situations.
FAQ 2: How does Melbourne's large Greek and Italian community — with specific prostate cancer dietary risk factors — engage with Abiranamo?
Melbourne's Greek community — one of the world's largest Greek diasporas outside Greece, concentrated in the northern suburbs of Oakleigh, Northcote, and Preston — and Italian community — concentrated in Carlton, Fitzroy, and Coburg — together constitute a significant proportion of Melbourne's population. Mediterranean dietary patterns and prostate cancer: the traditional Mediterranean diet (olive oil, vegetables, legumes, moderate red wine, fish, limited red meat) is associated with reduced prostate cancer risk and slower progression — the Lyon Diet Heart Study and Mediterranean Diet adherence studies suggest 15-25% reduction in prostate cancer mortality with sustained Mediterranean diet; Melbourne's Greek and Italian communities who maintain traditional Mediterranean diets may have modestly slower prostate cancer progression as a dietary benefit. However, Melbourne's assimilation has shifted dietary patterns for younger generation Greek and Italian Melburnians toward Australian dietary norms — reducing the Mediterranean diet's protective benefit. Abiranamo food interaction in Melbourne's Greek and Italian context: the Mediterranean diet's olive oil richness is highly relevant for Abiranamo's strict food interaction; a typical Greek Oakleigh Sunday lunch — grilled lamb with tzatziki (olive oil-heavy), spanakopita, and olive-based mezze — is extremely high in fat; Abiranamo must be taken at least 2 hours before such a meal or 1+ hours after, and the typical Italian Carlton family dinner of risotto with butter and Parmesan is similarly high-fat. Peter Mac's prostate cancer nurses counsel Melbourne's Greek and Italian patients specifically on Mediterranean meal timing for Abiranamo — the cultural food practices can be maintained with careful Abiranamo timing discipline.
FAQ 3: What is the PBS listing for Abiranamo in Australia and how does it affect Melbourne patients?
Australia's PBS covers Abiraterone Acetate (brand Zytiga, generic equivalent Abiranamo) for specific prostate cancer indications based on PBAC (Pharmaceutical Benefits Advisory Committee) positive recommendations. Current PBS Abiraterone listings relevant to Melbourne patients: mHSPC (metastatic hormone-sensitive prostate cancer) — Abiraterone + Prednisone listed for patients with high-risk or intermediate-risk mHSPC in combination with ADT; this was the 2021-era PBAC listing following LATITUDE and STAMPEDE evidence; and mCRPC (metastatic castration-resistant prostate cancer) — Abiraterone listed for mCRPC patients who have received prior docetaxel or are docetaxel-unsuitable. PBS prescribing requirements: medical oncologist or urologist with PBS authority; documentation of disease stage and prior treatment; and ongoing PBS renewal at 6-monthly intervals confirming disease progression criteria are met for continued listing. Melbourne PBS Abiranamo gaps: PBS listing updates lag international evidence — some newer STAMPEDE evidence supporting broader mHSPC indications may not yet be fully reflected in PBS authority criteria; patients who are PBS-authority eligible for mHSPC but face the 1-2 week PBS approval processing window benefit from Abiranamo from Unnati Pharmax as a bridge. Victoria's high-cost PBS Safety Net: Melbourne patients who exceed the Safety Net threshold (approximately AUD $1,500 annually in co-payments) receive further PBS subsidisation — for prostate cancer patients on multiple PBS medications (Abiranamo + Prednisone + ADT injections), reaching the Safety Net threshold provides additional cost relief that Peter Mac's social workers help calculate and communicate to patients.
FAQ 4: How does Melbourne's significant Chinese community engage with prostate cancer screening and Abiranamo treatment?
Melbourne's Chinese community — concentrated in Box Hill, Glen Waverley, and Doncaster in the eastern suburbs, and in the traditional CBD Chinatown — numbers approximately 280,000 in Greater Melbourne, one of Australia's largest Chinese urban populations. Chinese men's prostate cancer relationship has cultural and epidemiological dimensions: traditional Chinese medical culture does not emphasise prostate-specific screening — PSA testing is not culturally normalised in Chinese communities to the same degree as in Anglo-Celtic Australian communities; the concept of testing for a cancer you have no symptoms of is counterintuitive to traditional Chinese health frameworks where illness is felt before investigated. The consequence for Melbourne's Chinese prostate cancer patients: higher proportional rates of advanced-stage prostate cancer at diagnosis in Melbourne's Chinese community from lower PSA screening engagement; when diagnosed, metastatic disease is more commonly the presentation, placing Chinese Melbourne patients directly in the Abiranamo-eligible mHSPC or mCRPC category. Chinese medicine and Abiranamo interaction: Melbourne's Box Hill and Glen Waverley Chinese community maintains active traditional Chinese medicine (TCM) practice — acupuncture, herbal decoctions, and functional foods are integrated health practices; CYP enzyme-affecting Chinese herbs (some schisandra preparations, some licorice root preparations) could theoretically affect Abiranamo metabolism; Peter Mac's TCM-aware oncology nurses conduct respectful inquiry about TCM use and provide pharmacist review for specific preparations. Mandarin-language Peter Mac materials: Peter Mac provides Mandarin-language prostate cancer information — and Unnati Pharmax's Mandarin-capable customer service extends this to the medication supply phase for Melbourne's Chinese Abiranamo patients.
FAQ 5: How does Melbourne's world-class coffee culture interact with Abiranamo 250mg use?
Melbourne is globally recognised as one of the world's great coffee cities — flat white's birthplace (disputed between Melbourne and Wellington, but claimed passionately by Melburnians), the global café culture standard-setter with thousands of independent specialty coffee shops across Fitzroy, Collingwood, Carlton, and the CBD. Melbourne's coffee culture and Abiranamo: coffee itself — whether espresso, flat white, or filter — contains no calcium, magnesium, or aluminium; black coffee therefore has no significant cation chelation interaction with Abiranamo. However, Melbourne's flat white culture is dairy-based — a traditional flat white uses whole milk; Melbourne's café lactose-free, almond, oat, and soy milk alternatives vary in calcium content (oat milk and soy milk are often calcium-fortified to 120mg/100ml); calcium-fortified plant milk flat whites have significant calcium content that could interact with Abiranamo's absorption if the coffee is taken within 2 hours of the dose. The practical Melbourne Abiranamo-coffee protocol: plain espresso (no milk) — no interaction; flat white, cappuccino, or latte with dairy milk or calcium-fortified plant milk — 2-hour food-free window applies because the milk component contains calcium. For Melbourne prostate cancer patients who structure their morning around their café ritual, taking Abiranamo at bedtime (2+ hours after any evening meal) rather than in the morning eliminates the morning café interaction entirely — the most practical Melbourne-adapted Abiranamo timing approach. Peter Mac's oncology pharmacists specifically discuss the Melbourne coffee culture and Abiranamo timing in patient education — recognising that medication instructions must fit into patients' actual lives, not theoretical clinical scenarios.
Website
Email Id
Contact Number
+91-8265041513
Abiranamo-250-mg-Generic-Zytig-Melbourne
